These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 304943)

  • 1. Coagulation abnormalities in patients undergoing myocardial revascularization.
    Zajtchuk R; Collins GJ; Schuchmann GF; Holley PW; Hamaker WR
    J Thorac Cardiovasc Surg; 1978 Feb; 75(2):168-70. PubMed ID: 304943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation factors influencing thrombosis of aorta-coronary bypass grafts.
    Zajtchuk R; Collins GJ; Holley PW; Heydron WH; Schuchmann GF; Hamaker WR
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):309-11. PubMed ID: 299908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
    Shennib H; Endo M; Benhameid O
    Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery.
    Manchio JV; Gu J; Romar L; Brown J; Gammie J; Pierson RN; Griffith B; Poston RS
    Ann Thorac Surg; 2005 Jun; 79(6):1991-8. PubMed ID: 15919298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid significantly reduces blood loss associated with coronary revascularization.
    Rousou JA; Engelman RM; Flack JE; Deaton DW; Owen SG
    Ann Thorac Surg; 1995 Mar; 59(3):671-5. PubMed ID: 7887710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts.
    McEnany MT; Salzman EW; Mundth ED; DeSanctis RW; Harthorne JW; Weintraub RM; Gates S; Austen WG
    J Thorac Cardiovasc Surg; 1982 Jan; 83(1):81-9. PubMed ID: 7033673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of pulmonary embolism in open versus laparoscopic gastric bypass.
    Gargiulo NJ; Veith FJ; Lipsitz EC; Suggs WD; Ohki T; Goodman E; Vemulapalli P; Gibbs K; Teixeira J
    Ann Vasc Surg; 2007 Sep; 21(5):556-9. PubMed ID: 17823038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodilution during off-pump coronary artery bypass grafting: can we improve flow and reduce hypercoagulability?
    Güden M; Sanisoglu I; Sagbas E; Ergenoglu MU; Ozbek U; Akpinar B
    Heart Surg Forum; 2003; 6(5):399-402. PubMed ID: 14721820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
    Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation?
    Hausmann H; Topp H; Siniawski H; Holz S; Hetzer R
    Ann Thorac Surg; 1997 Nov; 64(5):1296-301; discussion 1302. PubMed ID: 9386693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of coagulation disorders].
    Esnaola-Rojas MM
    Rev Neurol; 1999 Dec 16-31; 29(12):1290-300. PubMed ID: 10652759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.